New

Platelet Rich Plasma Treatment Market

2021

Platelet Rich Plasma Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF)); Source (Autologous, Allogenic); Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others); End-Users (Hospitals and Clinics, Research Institutions) and Geography

| Report Code: TIPRE00023150 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Platelet Rich Plasma Treatment Market 2028 By Type ), Source, Application, End-Users and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Platelet rich plasma (PRP) is a type of blood plasma product that is simple, cost-effective as well as feasible treatment option. It is also called autologous conditioned plasma. It has extremely high healing capacities and is used for the healing of muscles, ligaments, and joints. PRP treatment utilizes a patient's healing system to improve injuries and helps to increase healing process speed. As this therapy consists of patients own cells, it is extremely safe and reliable. It is widely used among athletes. It provides quick and effective treatment of many medical conditions such as sports injuries.

MARKET DYNAMICS

The platelet rich plasma treatment market is anticipated to grow in the forecast period, owing to rising incidences of orthopedic diseases, musculoskeletal disorders, sport injuries, increasing cosmetic surgeries and increasing awareness for platelet-rich plasma (PRP) therapy. Moreover, expanding research activities, and growing application of PRP therapy in dental and oral surgical procedures may propel the market growth. In addition, the rising healthcare facilities in developing economies and technological advancements is expected to offer significant growth opportunities for the platelet rich plasma treatment market. However, high treatment costs, lack of reimbursement policies and difficulty regarding quality control may hamper the market growth.

MARKET SCOPE

The "Platelet Rich Plasma Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of platelet rich plasma treatment market with detailed market segmentation by type, source, application and end-users. The platelet rich plasma treatment market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in platelet rich plasma treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The platelet rich plasma treatment market are segmented on the basis of type, source, application and end-users. On the basis of type, the market is segmented into pure PRP, leucocyte-rich PRP, and leukocyte-rich fibrin (L-PRF). On the basis of source, the market is segmented as autologous, and allogenic. On the basis of application, the market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others .On the basis of end-users, the market is segmented into hospitals and clinics, and research institutions.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the platelet rich plasma treatment market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The platelet rich plasma treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting platelet rich plasma treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the platelet rich plasma treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the platelet rich plasma treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from platelet rich plasma treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for platelet rich plasma treatment in the global market. Below mentioned is the list of few companies engaged in the platelet rich plasma treatment market.

The report also includes the profiles of key players in platelet rich plasma treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Regen Lab
  •  ISTO Biologics
  •  Arthrex, Inc
  •  Terumo BCT, Inc
  •  EmCyte Corporation
  •  DePuy Synthes
  •  Zimmer Biomet, Inc.
  •  Stryker
  •  Glofinn OY
  •  AdiStem, Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Platelet Rich Plasma Treatment Market - By Type
1.3.2 Platelet Rich Plasma Treatment Market - By Source
1.3.3 Platelet Rich Plasma Treatment Market - By Application
1.3.4 Platelet Rich Plasma Treatment Market - By End-Users
1.3.5 Platelet Rich Plasma Treatment Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PLATELET RICH PLASMA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PLATELET RICH PLASMA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PLATELET RICH PLASMA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PLATELET RICH PLASMA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PLATELET RICH PLASMA TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. PLATELET RICH PLASMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PURE PRP
7.3.1. Overview
7.3.2. Pure PRP Market Forecast and Analysis
7.4. LEUCOCYTE-RICH PRP
7.4.1. Overview
7.4.2. Leucocyte-rich PRP Market Forecast and Analysis
7.5. LEUKOCYTE-RICH FIBRIN (L-PRF)
7.5.1. Overview
7.5.2. Leukocyte-rich Fibrin (L-PRF) Market Forecast and Analysis
8. PLATELET RICH PLASMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
8.1. OVERVIEW
8.2. SOURCE MARKET FORECASTS AND ANALYSIS
8.3. AUTOLOGOUS
8.3.1. Overview
8.3.2. Autologous Market Forecast and Analysis
8.4. ALLOGENIC
8.4.1. Overview
8.4.2. Allogenic Market Forecast and Analysis
9. PLATELET RICH PLASMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ORTHOPEDICS
9.3.1. Overview
9.3.2. Orthopedics Market Forecast and Analysis
9.4. DERMATOLOGY
9.4.1. Overview
9.4.2. Dermatology Market Forecast and Analysis
9.5. DENTAL
9.5.1. Overview
9.5.2. Dental Market Forecast and Analysis
9.6. CARDIAC MUSCLE INJURY
9.6.1. Overview
9.6.2. Cardiac Muscle Injury Market Forecast and Analysis
9.7. NERVE INJURY
9.7.1. Overview
9.7.2. Nerve Injury Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. PLATELET RICH PLASMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END-USERS
10.1. OVERVIEW
10.2. END-USERS MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. RESEARCH INSTITUTIONS
10.4.1. Overview
10.4.2. Research Institutions Market Forecast and Analysis

11. PLATELET RICH PLASMA TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Platelet Rich Plasma Treatment Market Overview
11.1.2 North America Platelet Rich Plasma Treatment Market Forecasts and Analysis
11.1.3 North America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Type
11.1.4 North America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Source
11.1.5 North America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Application
11.1.6 North America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By End-Users
11.1.7 North America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 Canada Platelet Rich Plasma Treatment Market
11.1.7.1.1 Canada Platelet Rich Plasma Treatment Market by Type
11.1.7.1.2 Canada Platelet Rich Plasma Treatment Market by Source
11.1.7.1.3 Canada Platelet Rich Plasma Treatment Market by Application
11.1.7.1.4 Canada Platelet Rich Plasma Treatment Market by End-Users
11.1.7.2 Mexico Platelet Rich Plasma Treatment Market
11.1.7.2.1 Mexico Platelet Rich Plasma Treatment Market by Type
11.1.7.2.2 Mexico Platelet Rich Plasma Treatment Market by Source
11.1.7.2.3 Mexico Platelet Rich Plasma Treatment Market by Application
11.1.7.2.4 Mexico Platelet Rich Plasma Treatment Market by End-Users
11.1.7.3 US Platelet Rich Plasma Treatment Market
11.1.7.3.1 US Platelet Rich Plasma Treatment Market by Type
11.1.7.3.2 US Platelet Rich Plasma Treatment Market by Source
11.1.7.3.3 US Platelet Rich Plasma Treatment Market by Application
11.1.7.3.4 US Platelet Rich Plasma Treatment Market by End-Users
11.2. EUROPE
11.2.1 Europe Platelet Rich Plasma Treatment Market Overview
11.2.2 Europe Platelet Rich Plasma Treatment Market Forecasts and Analysis
11.2.3 Europe Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Type
11.2.4 Europe Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Source
11.2.5 Europe Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Application
11.2.6 Europe Platelet Rich Plasma Treatment Market Forecasts and Analysis - By End-Users
11.2.7 Europe Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Platelet Rich Plasma Treatment Market
11.2.7.1.1 Germany Platelet Rich Plasma Treatment Market by Type
11.2.7.1.2 Germany Platelet Rich Plasma Treatment Market by Source
11.2.7.1.3 Germany Platelet Rich Plasma Treatment Market by Application
11.2.7.1.4 Germany Platelet Rich Plasma Treatment Market by End-Users
11.2.7.2 France Platelet Rich Plasma Treatment Market
11.2.7.2.1 France Platelet Rich Plasma Treatment Market by Type
11.2.7.2.2 France Platelet Rich Plasma Treatment Market by Source
11.2.7.2.3 France Platelet Rich Plasma Treatment Market by Application
11.2.7.2.4 France Platelet Rich Plasma Treatment Market by End-Users
11.2.7.3 Italy Platelet Rich Plasma Treatment Market
11.2.7.3.1 Italy Platelet Rich Plasma Treatment Market by Type
11.2.7.3.2 Italy Platelet Rich Plasma Treatment Market by Source
11.2.7.3.3 Italy Platelet Rich Plasma Treatment Market by Application
11.2.7.3.4 Italy Platelet Rich Plasma Treatment Market by End-Users
11.2.7.4 Spain Platelet Rich Plasma Treatment Market
11.2.7.4.1 Spain Platelet Rich Plasma Treatment Market by Type
11.2.7.4.2 Spain Platelet Rich Plasma Treatment Market by Source
11.2.7.4.3 Spain Platelet Rich Plasma Treatment Market by Application
11.2.7.4.4 Spain Platelet Rich Plasma Treatment Market by End-Users
11.2.7.5 United Kingdom Platelet Rich Plasma Treatment Market
11.2.7.5.1 United Kingdom Platelet Rich Plasma Treatment Market by Type
11.2.7.5.2 United Kingdom Platelet Rich Plasma Treatment Market by Source
11.2.7.5.3 United Kingdom Platelet Rich Plasma Treatment Market by Application
11.2.7.5.4 United Kingdom Platelet Rich Plasma Treatment Market by End-Users
11.2.7.6 Rest of Europe Platelet Rich Plasma Treatment Market
11.2.7.6.1 Rest of Europe Platelet Rich Plasma Treatment Market by Type
11.2.7.6.2 Rest of Europe Platelet Rich Plasma Treatment Market by Source
11.2.7.6.3 Rest of Europe Platelet Rich Plasma Treatment Market by Application
11.2.7.6.4 Rest of Europe Platelet Rich Plasma Treatment Market by End-Users
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Platelet Rich Plasma Treatment Market Overview
11.3.2 Asia-Pacific Platelet Rich Plasma Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Source
11.3.5 Asia-Pacific Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Platelet Rich Plasma Treatment Market Forecasts and Analysis - By End-Users
11.3.7 Asia-Pacific Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Platelet Rich Plasma Treatment Market
11.3.7.1.1 Australia Platelet Rich Plasma Treatment Market by Type
11.3.7.1.2 Australia Platelet Rich Plasma Treatment Market by Source
11.3.7.1.3 Australia Platelet Rich Plasma Treatment Market by Application
11.3.7.1.4 Australia Platelet Rich Plasma Treatment Market by End-Users
11.3.7.2 China Platelet Rich Plasma Treatment Market
11.3.7.2.1 China Platelet Rich Plasma Treatment Market by Type
11.3.7.2.2 China Platelet Rich Plasma Treatment Market by Source
11.3.7.2.3 China Platelet Rich Plasma Treatment Market by Application
11.3.7.2.4 China Platelet Rich Plasma Treatment Market by End-Users
11.3.7.3 India Platelet Rich Plasma Treatment Market
11.3.7.3.1 India Platelet Rich Plasma Treatment Market by Type
11.3.7.3.2 India Platelet Rich Plasma Treatment Market by Source
11.3.7.3.3 India Platelet Rich Plasma Treatment Market by Application
11.3.7.3.4 India Platelet Rich Plasma Treatment Market by End-Users
11.3.7.4 Japan Platelet Rich Plasma Treatment Market
11.3.7.4.1 Japan Platelet Rich Plasma Treatment Market by Type
11.3.7.4.2 Japan Platelet Rich Plasma Treatment Market by Source
11.3.7.4.3 Japan Platelet Rich Plasma Treatment Market by Application
11.3.7.4.4 Japan Platelet Rich Plasma Treatment Market by End-Users
11.3.7.5 South Korea Platelet Rich Plasma Treatment Market
11.3.7.5.1 South Korea Platelet Rich Plasma Treatment Market by Type
11.3.7.5.2 South Korea Platelet Rich Plasma Treatment Market by Source
11.3.7.5.3 South Korea Platelet Rich Plasma Treatment Market by Application
11.3.7.5.4 South Korea Platelet Rich Plasma Treatment Market by End-Users
11.3.7.6 Rest of Asia-Pacific Platelet Rich Plasma Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Platelet Rich Plasma Treatment Market by Type
11.3.7.6.2 Rest of Asia-Pacific Platelet Rich Plasma Treatment Market by Source
11.3.7.6.3 Rest of Asia-Pacific Platelet Rich Plasma Treatment Market by Application
11.3.7.6.4 Rest of Asia-Pacific Platelet Rich Plasma Treatment Market by End-Users
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Platelet Rich Plasma Treatment Market Overview
11.4.2 Middle East and Africa Platelet Rich Plasma Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Source
11.4.5 Middle East and Africa Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Platelet Rich Plasma Treatment Market Forecasts and Analysis - By End-Users
11.4.7 Middle East and Africa Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Platelet Rich Plasma Treatment Market
11.4.7.1.1 South Africa Platelet Rich Plasma Treatment Market by Type
11.4.7.1.2 South Africa Platelet Rich Plasma Treatment Market by Source
11.4.7.1.3 South Africa Platelet Rich Plasma Treatment Market by Application
11.4.7.1.4 South Africa Platelet Rich Plasma Treatment Market by End-Users
11.4.7.2 Saudi Arabia Platelet Rich Plasma Treatment Market
11.4.7.2.1 Saudi Arabia Platelet Rich Plasma Treatment Market by Type
11.4.7.2.2 Saudi Arabia Platelet Rich Plasma Treatment Market by Source
11.4.7.2.3 Saudi Arabia Platelet Rich Plasma Treatment Market by Application
11.4.7.2.4 Saudi Arabia Platelet Rich Plasma Treatment Market by End-Users
11.4.7.3 U.A.E Platelet Rich Plasma Treatment Market
11.4.7.3.1 U.A.E Platelet Rich Plasma Treatment Market by Type
11.4.7.3.2 U.A.E Platelet Rich Plasma Treatment Market by Source
11.4.7.3.3 U.A.E Platelet Rich Plasma Treatment Market by Application
11.4.7.3.4 U.A.E Platelet Rich Plasma Treatment Market by End-Users
11.4.7.4 Rest of Middle East and Africa Platelet Rich Plasma Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Platelet Rich Plasma Treatment Market by Type
11.4.7.4.2 Rest of Middle East and Africa Platelet Rich Plasma Treatment Market by Source
11.4.7.4.3 Rest of Middle East and Africa Platelet Rich Plasma Treatment Market by Application
11.4.7.4.4 Rest of Middle East and Africa Platelet Rich Plasma Treatment Market by End-Users
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Platelet Rich Plasma Treatment Market Overview
11.5.2 South and Central America Platelet Rich Plasma Treatment Market Forecasts and Analysis
11.5.3 South and Central America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Type
11.5.4 South and Central America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Source
11.5.5 South and Central America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Application
11.5.6 South and Central America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By End-Users
11.5.7 South and Central America Platelet Rich Plasma Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Platelet Rich Plasma Treatment Market
11.5.7.1.1 Brazil Platelet Rich Plasma Treatment Market by Type
11.5.7.1.2 Brazil Platelet Rich Plasma Treatment Market by Source
11.5.7.1.3 Brazil Platelet Rich Plasma Treatment Market by Application
11.5.7.1.4 Brazil Platelet Rich Plasma Treatment Market by End-Users
11.5.7.2 Argentina Platelet Rich Plasma Treatment Market
11.5.7.2.1 Argentina Platelet Rich Plasma Treatment Market by Type
11.5.7.2.2 Argentina Platelet Rich Plasma Treatment Market by Source
11.5.7.2.3 Argentina Platelet Rich Plasma Treatment Market by Application
11.5.7.2.4 Argentina Platelet Rich Plasma Treatment Market by End-Users
11.5.7.3 Rest of South and Central America Platelet Rich Plasma Treatment Market
11.5.7.3.1 Rest of South and Central America Platelet Rich Plasma Treatment Market by Type
11.5.7.3.2 Rest of South and Central America Platelet Rich Plasma Treatment Market by Source
11.5.7.3.3 Rest of South and Central America Platelet Rich Plasma Treatment Market by Application
11.5.7.3.4 Rest of South and Central America Platelet Rich Plasma Treatment Market by End-Users

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. PLATELET RICH PLASMA TREATMENT MARKET, KEY COMPANY PROFILES
13.1. REGEN LAB
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ISTO BIOLOGICS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ARTHREX, INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TERUMO BCT, INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. EMCYTE CORPORATION
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. DEPUY SYNTHES
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ZIMMER BIOMET, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. STRYKER
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLOFINN OY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ADISTEM, LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Regen Lab
2. ISTO Biologics
3. Arthrex, Inc
4. Terumo BCT, Inc
5. EmCyte Corporation
6. DePuy Synthes
7. Zimmer Biomet, Inc.
8. Stryker
9. Glofinn OY
10. AdiStem, Ltd.
TIPRE00023150
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.